Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (1 trial)
Papilloma (Phase 3)
Uterine Cervical Neoplasms (Phase 3)
Trials (1 total)
Trial APIs (1 total)